Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children.
Nguyên P, Reynaud J, Pouzol P, Munzer M, Richard O, François P. Nguyên P, et al. Among authors: munzer m. Eur J Pediatr. 1994 Sep;153(9):646-9. doi: 10.1007/BF02190684. Eur J Pediatr. 1994. PMID: 7957422
[Acquired anticoagulants in children. Apropos of a series of 35 cases].
Munzer M, Behar C, Droulle C. Munzer M, et al. Arch Fr Pediatr. 1988 Nov;45(9):629-33. Arch Fr Pediatr. 1988. PMID: 3069068 Review. French.
[Cutaneous granulomatous lesions disclosing ataxia-telangiectasia].
Corbisier A, Eschard C, Motte J, Munzer M, Barhoum K, Kalis B, Grosshans E. Corbisier A, et al. Among authors: munzer m. Ann Dermatol Venereol. 1999 Aug-Sep;126(8-9):608-11. Ann Dermatol Venereol. 1999. PMID: 10530349 French.
[Ifosfamide induced encephalopathy: 15 observations].
Dufour C, Grill J, Sabouraud P, Behar C, Munzer M, Motte J, Oberlin O, Paci A, Hartmann O. Dufour C, et al. Among authors: munzer m. Arch Pediatr. 2006 Feb;13(2):140-5. doi: 10.1016/j.arcped.2005.10.021. Epub 2005 Dec 20. Arch Pediatr. 2006. PMID: 16364615 French.
Ifosfamide was administered at a posology between 5.4 and 15 g/m(2)/course, associated with other antimitotics such as actinomycin D, etoposide or vincristine. ...
Ifosfamide was administered at a posology between 5.4 and 15 g/m(2)/course, associated with other antimitotics such as actinomycin D, …
Lymphocyte data in Epstein-Barr-virus induced post-transplant lymphoproliferative disorder treated by rituximab.
Entz-Werle N, Cojean N, Barats A, Eyer D, Munzer M, Uring-Lambert B, Falkenrodt A, Babin A, Lutz P. Entz-Werle N, et al. Among authors: munzer m. Pediatr Transplant. 2003 Aug;7(4):277-81. doi: 10.1034/j.1399-3046.2003.00091.x. Pediatr Transplant. 2003. PMID: 12890005
[Kaposiform haemangioendothelioma associated with B-cell acute lymphoblastic leukemia].
Fichel F, Eschard C, Zachar D, Munzer M, Bernard P, Grange F. Fichel F, et al. Among authors: munzer m. Ann Dermatol Venereol. 2013 Mar;140(3):209-14. doi: 10.1016/j.annder.2012.12.009. Epub 2013 Jan 7. Ann Dermatol Venereol. 2013. PMID: 23466155 French.
[Disseminated osseous lymphangiomatosis. Apropos of 6 case reports].
Daoud S, Lefort G, Munzer M, Behar S, Bouche-Pillon MA, Lefebvre F, Gomès H. Daoud S, et al. Among authors: munzer m. Chir Pediatr. 1988;29(6):342-8. Chir Pediatr. 1988. PMID: 3228942 French.
[Liposarcoma in children. Apropos of 3 cases and a review of the literature].
Bouche-Pillon MA, Behar C, Munzer M, Gaillard D, Lefebvre F, Lefort G, Daoud S. Bouche-Pillon MA, et al. Among authors: munzer m. Chir Pediatr. 1989;30(4):181-4. Chir Pediatr. 1989. PMID: 2695264 Review. French.
Transient remission of childhood acute lymphoblastic and myeloid leukemia without any cytostatic treatment: 2 case reports and a review of literature.
Pluchart C, Munzer M, Mauran P, Abély M. Pluchart C, et al. Among authors: munzer m. J Pediatr Hematol Oncol. 2015 Jan;37(1):68-71. doi: 10.1097/MPH.0000000000000152. J Pediatr Hematol Oncol. 2015. PMID: 25411866 Review.
Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, Bergeron C, Defachelles AS, Gentet JC, Schmitt C, Rubie H, Munzer M, Plantaz D, Deville A, Minard V, Corradini N, Leverger G, de Vathaire F. Oberlin O, et al. Among authors: munzer m. J Clin Oncol. 2009 Nov 10;27(32):5350-5. doi: 10.1200/JCO.2008.17.5257. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826134
RESULTS: The median dose of ifosfamide was 54 g/m(2) (range, 18 to 117 g/m(2)). After a median follow-up of 10 years, 89.5% of patients had normal tubular function, and 78.5% had normal glomerular function rate (GFR). ...
RESULTS: The median dose of ifosfamide was 54 g/m(2) (range, 18 to 117 g/m(2)). After a median follow-up of 10 years, 89.5% of …
80 results
Jump to page
Feedback